Canadian superhospital CHUM in Montreal chooses XECAN’s Face ID Safety Solution to be part of its clinical treatment time out protocol for Radiation Oncology treatments at their brand new Cancer Center. CHUM's Radiation Oncology Department has 10 treatment rooms. The implementation is expected to be completed during the first quarter of 2020.
After years of evaluation of various technologies in the marketplace, CHUM has selected the Xecan smart MOSAIQ facial recognition technology.. XECAN’s Smart Face ID solution will be integrated with Mosaiq, the centers EMR to clear the MOSAIQ patient safety interlock. , The technology will ensure the highest level of patient safety available on the market today. Xecan’s unique technology also allows for increased workflow efficiencies and a more positive patient experience.
To ensure Xecan/Mosaiq compatibility, Xecan has entered into a Vendor Interoperability Program Agreement with Elekta. Under this agreement, Xecan has re-designed and re-developed its patient verification component based on the Elekta PatientVerify platform available in version 2.6 and higher. This allows Xecan to use the standardized Elekta foundation for patient safety verification, which is fully supported by Elekta standard releases.